The Discounted Cash Flow (DCF) valuation of Xphyto Therapeutics Corp (XPHY.CN) is (2.54) CAD. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on DCF is -612.3%.
Based on the latest price of 0.50 CAD and our DCF valuation, Xphyto Therapeutics Corp (XPHY.CN) is a sell. selling XPHY.CN stocks now will result in a potential gain of 612.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 10.2% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.62) - (1.70) | (2.54) |
| Upside | -1235.1% - -443.2% | -612.3% |